Stay updated on CAcTUS: ctDNA-Guided Switch Clinical Trial
Sign up to get notified when there's something new on the CAcTUS: ctDNA-Guided Switch Clinical Trial page.

Latest updates to the CAcTUS: ctDNA-Guided Switch Clinical Trial page
- CheckyesterdayChange DetectedThe footer site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe study page now displays a 403 Forbidden message instead of the usual study details, indicating restricted access to the record rather than an update to the study information.SummaryDifference19%

- Check36 days agoChange DetectedThe page’s related topics section is trimmed by deleting the melanoma keyword, the 'related topics' header, and the 'MedlinePlus Genetics' item. This reduces topic tagging and external cross-links but leaves the study content unchanged.SummaryDifference0.2%

- Check50 days agoChange DetectedMelanoma and related topics were added to the page's related topics/keywords. The revision tag was updated from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check65 days agoChange DetectedMelanoma, the related topics heading, and the MedlinePlus Genetics entry were removed from the study's related topics list. This affects how the record is categorized and linked to cancer and genetics resources for discovery.SummaryDifference0.2%

Stay in the know with updates to CAcTUS: ctDNA-Guided Switch Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAcTUS: ctDNA-Guided Switch Clinical Trial page.